Related Articles
Application evaluation of DCE‑MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast‑enhanced magnetic resonance imaging
Dynamic contrast‑enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features
Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast‑enhanced MRI
In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor